Member Info for Goldie24_7

SYNT starting to look seriously mispriced here.

The market is still valuing this like a distressed business… but the backdrop is changing rapidly.

Everyone focused on debt and refinancing for months.

Now look what’s happening:

✅ Debt falling

✅ Positive cash flow improving

✅ Refinancing progressing

✅ No equity raise flagged

✅ Q2 momentum improving

✅ Two disposals expected this month bringing MORE cash into the bank

But here’s the BIGGER point the market may be missing:

The Middle East conflict and oil shock could actually BENEFIT Synthomer operationally.

Oil prices are surging as bombs land in the UAE and Iran tensions escalate. Global petrochemical and raw material supply chains are under major stress.

Asian competitors are struggling with shipping disruption, higher feedstock costs and logistics chaos.

Meanwhile Synthomer has already stated:

* its global supply chains remain robust

* pricing power is improving

* shipping volumes are increasing due to disruption to competitors

* margins and volumes are expected to improve strongly in Q2

That is HUGE.

This is exactly how cyclical recovery reratings happen:

1. Balance sheet fear fades

2. Asset disposals bring in cash

3. Margins recover

4. Supply tightens globally

5. Competitors struggle

6. Earnings surprise to the upside

The market cap still looks tiny versus the scale of the business and replacement value of its global operations.

And now geopolitical disruption is creating a pricing environment where strong operators with secure raw material access can outperform massively.

If oil stays elevated and Middle East disruption continues, weaker competitors get squeezed first.

SYNT may actually emerge stronger.

Technicals are also improving:

* Momentum indicators turning bullish

* MACD improving

* Selling exhaustion visible

* Recovery volume building

High risk? Of course.

But if disposals complete this month and debt drops further, the upside rerating could be violent because sentiment is still extremely bearish while fundamentals are improving underneath.

Feels like the market is still trading the old story while the new story is already unfolding.

DYOR.

p.s Institutions accumulating!

#SYNT is entering a compelling re-rating phase as operational strength and market positioning begin to translate into real financial momentum.

The company holds a clear advantage: strong raw material availability while competitors face ongoing feedstock constraints. Disruptions in the Strait of Hormuz have further amplified this, leaving peers out of position and effectively handing #SYNT an estimated ~9-month window of advantage.

Earnings momentum is accelerating EBITDA is expected to grow 2–3x in Q2, driven by rising revenues, +500bps margin expansion, and disciplined cost control.

Geopolitical dynamics, including the Iran situation, are acting as a tailwind, positioning the business in the right place at the right time with increased exposure to higher-margin opportunities.

Strategically, the transformation is well underway. Four divestments are unlocking cash, with two imminent and the remainder in H2. A robust financing package underpins this shift—providing stability, flexibility, and a clear path forward.

Financially, the progress is tangible: stronger revenues, improved margins, reduced costs, positive free cash flow, and a balance sheet secured through refinancing to 2029.

Looking ahead, a steady stream of catalysts is expected, including supportive policy developments from Brussels that could drive further upside across key segments.

The investment case is strengthening: the business is now more stable, momentum is building, and institutional investors are actively accumulating.

Valuation remains attractive. The average broker target sits at ~260p, with Peel Hunt at 460p, while the stock traded above 300p just three years ago, highlighting the potential for re-rating.

With ~90% regional production and world-class procurement, the competitive moat is firmly in place.

As momentum builds and the story gains traction, the conditions for a meaningful reprice and potential short squeeze—are increasingly aligned.